Review



e coli coliforms chromogenic medium  (Condalab)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Condalab e coli coliforms chromogenic medium
    E Coli Coliforms Chromogenic Medium, supplied by Condalab, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/e%2E+coli-chromogenic+medium/1356+agar+base+iso+pseudomonas/10__61310_slash_mjst__v23i1__2393-78-26-32
    Average 86 stars, based on 1 article reviews
    e coli coliforms chromogenic medium - by Bioz Stars, 2026-09
    86/100 stars

    Images

    Related Articles

    other:

    Article Title: Value Chain Hygiene Practices and Microbial Contamination of Street and Market Vended Ready-to-Eat grasshopper, Ruspolia differens in Uganda: Implications for food safety and public health
    Article Snippet: Each lter was transferred to the E. coli-chromogenic medium (Condalab Conda S.A, Madrid, Spain).



    Similar Products

    e coli coliforms chromogenic medium  (Condalab)
    86
    Condalab e coli coliforms chromogenic medium
    E Coli Coliforms Chromogenic Medium, supplied by Condalab, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/e%2E+coli-chromogenic+medium/1356+agar+base+iso+pseudomonas/10__61310_slash_mjst__v23i1__2393-78-26-32
    Average 86 stars, based on 1 article reviews
    e coli coliforms chromogenic medium - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    e. coli chromogenic medium hb7001  (Haibo Inc)
    90
    Haibo Inc e. coli chromogenic medium hb7001
    E. Coli Chromogenic Medium Hb7001, supplied by Haibo Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/e%2E+coli-chromogenic+medium/macconkey+agar+hb7001/pm40430820-40-10-15
    Average 90 stars, based on 1 article reviews
    e. coli chromogenic medium hb7001 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    e. coli / s. aureus chromogenic medium  (Qingdao Hope Bio)
    90
    Qingdao Hope Bio e. coli / s. aureus chromogenic medium
    E. Coli / S. Aureus Chromogenic Medium, supplied by Qingdao Hope Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/e%2E+coli-chromogenic+medium/candida+chromogenic+medium++ccm++hb7015+/pm39787691-47-14-24
    Average 90 stars, based on 1 article reviews
    e. coli / s. aureus chromogenic medium - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    e. coli chromogenic medium hb7003-7  (Haibo Inc)
    90
    Haibo Inc e. coli chromogenic medium hb7003-7
    Improved of the therapeutic effect in a peritonitis–sepsis infection model in mice by using FMEV. A) Scheme of the experimental protocol for the mouse peritonitis–sepsis model. B) Survival rates of mice with peritonitis–sepsis ( n = 7). Mice were infected with a lethal dose of <t>E.</t> <t>coli</t> B2 (4.0 × 10 7 CFU) in the presence of PBS, PB (8 mg kg −1 ), PLU (16 mg kg −1 ), PB + PLU (8 mg kg −1 + 16 mg kg −1 ), and FMEV (PB: 8 mg kg −1 + PLU: 16 mg kg −1 ). P ‐values were determined using the two‐sided, log[rank] (Mantel–Cox) test. * p < 0.05. C–G) Bacterial load (expressed as Log10 CFU) of E. coli B2 present in the heart (C), liver (D), spleen (E), lung (F), and kidney (G); this was evaluated at 48 h via a tenfold serial dilution technique. H) Representative photomicrographs of the H&E and Masson staining of the heart, liver, spleen, lung, and kidney. The arrow indicates the pathological lesions. The results are presented as the mean ± s.d. ( n = 7). Significance was determined by Tukey's multiple comparisons test following one‐way ANOVA. ns, not significant. ** p < 0.01 and *** p < 0.001.
    E. Coli Chromogenic Medium Hb7003 7, supplied by Haibo Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/e%2E+coli-chromogenic+medium/e++coli+chromogenic+medium++hb7003+7+/pmc11831456-178-13-21
    Average 90 stars, based on 1 article reviews
    e. coli chromogenic medium hb7003-7 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    e coli chromogenic medium  (Haibo Inc)
    86
    Haibo Inc e coli chromogenic medium
    Figure 6. Improved of the therapeutic effect in a peritonitis–sepsis infection model in mice by using FMEV. A) Scheme of the experimental protocol for the mouse peritonitis–sepsis model. B) Survival rates of mice with peritonitis–sepsis (n = 7). Mice were infected with a lethal dose of <t>E.</t> <t>coli</t> B2 (4.0 × 107 CFU) in the presence of PBS, PB (8 mg kg−1), PLU (16 mg kg−1), PB + PLU (8 mg kg−1 + 16 mg kg−1), and FMEV (PB: 8 mg kg−1 + PLU: 16 mg kg−1). P-values were determined using the two-sided, log[rank] (Mantel–Cox) test. *p < 0.05. C–G) Bacterial load (expressed as Log10 CFU) of E. coli B2 present in the heart (C), liver (D), spleen (E), lung (F), and kidney (G); this was evaluated at 48 h via a tenfold serial dilution technique. H) Representative photomicrographs of the H&E and Masson staining of the heart, liver, spleen, lung, and kidney. The arrow indicates the pathological lesions. The results are presented as the mean ± s.d. (n = 7). Significance was determined by Tukey’s multiple comparisons test following one-way ANOVA. ns, not significant. **p < 0.01 and ***p < 0.001.
    E Coli Chromogenic Medium, supplied by Haibo Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/e%2E+coli-chromogenic+medium/chromogenic+medium+salmonella/pm39721033-273-13-21
    Average 86 stars, based on 1 article reviews
    e coli chromogenic medium - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    e. coli chromogenic medium  (HiMedia Laboratories)
    90
    HiMedia Laboratories e. coli chromogenic medium
    Figure 6. Improved of the therapeutic effect in a peritonitis–sepsis infection model in mice by using FMEV. A) Scheme of the experimental protocol for the mouse peritonitis–sepsis model. B) Survival rates of mice with peritonitis–sepsis (n = 7). Mice were infected with a lethal dose of <t>E.</t> <t>coli</t> B2 (4.0 × 107 CFU) in the presence of PBS, PB (8 mg kg−1), PLU (16 mg kg−1), PB + PLU (8 mg kg−1 + 16 mg kg−1), and FMEV (PB: 8 mg kg−1 + PLU: 16 mg kg−1). P-values were determined using the two-sided, log[rank] (Mantel–Cox) test. *p < 0.05. C–G) Bacterial load (expressed as Log10 CFU) of E. coli B2 present in the heart (C), liver (D), spleen (E), lung (F), and kidney (G); this was evaluated at 48 h via a tenfold serial dilution technique. H) Representative photomicrographs of the H&E and Masson staining of the heart, liver, spleen, lung, and kidney. The arrow indicates the pathological lesions. The results are presented as the mean ± s.d. (n = 7). Significance was determined by Tukey’s multiple comparisons test following one-way ANOVA. ns, not significant. **p < 0.01 and ***p < 0.001.
    E. Coli Chromogenic Medium, supplied by HiMedia Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/e%2E+coli-chromogenic+medium/chromogenic+e++coli+medium/pm39639426-28-4-8
    Average 90 stars, based on 1 article reviews
    e. coli chromogenic medium - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    e. coli chromogenic medium  (BioMaxima SA)
    90
    BioMaxima SA e. coli chromogenic medium
    Figure 6. Improved of the therapeutic effect in a peritonitis–sepsis infection model in mice by using FMEV. A) Scheme of the experimental protocol for the mouse peritonitis–sepsis model. B) Survival rates of mice with peritonitis–sepsis (n = 7). Mice were infected with a lethal dose of <t>E.</t> <t>coli</t> B2 (4.0 × 107 CFU) in the presence of PBS, PB (8 mg kg−1), PLU (16 mg kg−1), PB + PLU (8 mg kg−1 + 16 mg kg−1), and FMEV (PB: 8 mg kg−1 + PLU: 16 mg kg−1). P-values were determined using the two-sided, log[rank] (Mantel–Cox) test. *p < 0.05. C–G) Bacterial load (expressed as Log10 CFU) of E. coli B2 present in the heart (C), liver (D), spleen (E), lung (F), and kidney (G); this was evaluated at 48 h via a tenfold serial dilution technique. H) Representative photomicrographs of the H&E and Masson staining of the heart, liver, spleen, lung, and kidney. The arrow indicates the pathological lesions. The results are presented as the mean ± s.d. (n = 7). Significance was determined by Tukey’s multiple comparisons test following one-way ANOVA. ns, not significant. **p < 0.01 and ***p < 0.001.
    E. Coli Chromogenic Medium, supplied by BioMaxima SA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/e%2E+coli-chromogenic+medium/e++coli+chromogenic+medium/pmc10902717-93-36-43
    Average 90 stars, based on 1 article reviews
    e. coli chromogenic medium - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    e. coli -chromogenic medium  (Condalab)
    90
    Condalab e. coli -chromogenic medium
    Figure 6. Improved of the therapeutic effect in a peritonitis–sepsis infection model in mice by using FMEV. A) Scheme of the experimental protocol for the mouse peritonitis–sepsis model. B) Survival rates of mice with peritonitis–sepsis (n = 7). Mice were infected with a lethal dose of <t>E.</t> <t>coli</t> B2 (4.0 × 107 CFU) in the presence of PBS, PB (8 mg kg−1), PLU (16 mg kg−1), PB + PLU (8 mg kg−1 + 16 mg kg−1), and FMEV (PB: 8 mg kg−1 + PLU: 16 mg kg−1). P-values were determined using the two-sided, log[rank] (Mantel–Cox) test. *p < 0.05. C–G) Bacterial load (expressed as Log10 CFU) of E. coli B2 present in the heart (C), liver (D), spleen (E), lung (F), and kidney (G); this was evaluated at 48 h via a tenfold serial dilution technique. H) Representative photomicrographs of the H&E and Masson staining of the heart, liver, spleen, lung, and kidney. The arrow indicates the pathological lesions. The results are presented as the mean ± s.d. (n = 7). Significance was determined by Tukey’s multiple comparisons test following one-way ANOVA. ns, not significant. **p < 0.01 and ***p < 0.001.
    E. Coli Chromogenic Medium, supplied by Condalab, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/e%2E+coli-chromogenic+medium/e++coli+chromogenic+medium/pmc10875366-156-6-10
    Average 90 stars, based on 1 article reviews
    e. coli -chromogenic medium - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Improved of the therapeutic effect in a peritonitis–sepsis infection model in mice by using FMEV. A) Scheme of the experimental protocol for the mouse peritonitis–sepsis model. B) Survival rates of mice with peritonitis–sepsis ( n = 7). Mice were infected with a lethal dose of E. coli B2 (4.0 × 10 7 CFU) in the presence of PBS, PB (8 mg kg −1 ), PLU (16 mg kg −1 ), PB + PLU (8 mg kg −1 + 16 mg kg −1 ), and FMEV (PB: 8 mg kg −1 + PLU: 16 mg kg −1 ). P ‐values were determined using the two‐sided, log[rank] (Mantel–Cox) test. * p < 0.05. C–G) Bacterial load (expressed as Log10 CFU) of E. coli B2 present in the heart (C), liver (D), spleen (E), lung (F), and kidney (G); this was evaluated at 48 h via a tenfold serial dilution technique. H) Representative photomicrographs of the H&E and Masson staining of the heart, liver, spleen, lung, and kidney. The arrow indicates the pathological lesions. The results are presented as the mean ± s.d. ( n = 7). Significance was determined by Tukey's multiple comparisons test following one‐way ANOVA. ns, not significant. ** p < 0.01 and *** p < 0.001.

    Journal: Advanced Science

    Article Title: A Milk Extracellular Vesicle‐Based Nanoplatform Enhances Combination Therapy Against Multidrug‐Resistant Bacterial Infections

    doi: 10.1002/advs.202406496

    Figure Lengend Snippet: Improved of the therapeutic effect in a peritonitis–sepsis infection model in mice by using FMEV. A) Scheme of the experimental protocol for the mouse peritonitis–sepsis model. B) Survival rates of mice with peritonitis–sepsis ( n = 7). Mice were infected with a lethal dose of E. coli B2 (4.0 × 10 7 CFU) in the presence of PBS, PB (8 mg kg −1 ), PLU (16 mg kg −1 ), PB + PLU (8 mg kg −1 + 16 mg kg −1 ), and FMEV (PB: 8 mg kg −1 + PLU: 16 mg kg −1 ). P ‐values were determined using the two‐sided, log[rank] (Mantel–Cox) test. * p < 0.05. C–G) Bacterial load (expressed as Log10 CFU) of E. coli B2 present in the heart (C), liver (D), spleen (E), lung (F), and kidney (G); this was evaluated at 48 h via a tenfold serial dilution technique. H) Representative photomicrographs of the H&E and Masson staining of the heart, liver, spleen, lung, and kidney. The arrow indicates the pathological lesions. The results are presented as the mean ± s.d. ( n = 7). Significance was determined by Tukey's multiple comparisons test following one‐way ANOVA. ns, not significant. ** p < 0.01 and *** p < 0.001.

    Article Snippet: CAMHB broth (HB6231‐1), BHI broth (HB8297‐1), agar powder (HB8274‐1), Salmonella chromogenic medium (HB7007‐1), E. coli chromogenic medium (HB7003‐7) were purchased from Haibo (Qingdao, China).

    Techniques: Infection, Serial Dilution, Staining

    Figure 6. Improved of the therapeutic effect in a peritonitis–sepsis infection model in mice by using FMEV. A) Scheme of the experimental protocol for the mouse peritonitis–sepsis model. B) Survival rates of mice with peritonitis–sepsis (n = 7). Mice were infected with a lethal dose of E. coli B2 (4.0 × 107 CFU) in the presence of PBS, PB (8 mg kg−1), PLU (16 mg kg−1), PB + PLU (8 mg kg−1 + 16 mg kg−1), and FMEV (PB: 8 mg kg−1 + PLU: 16 mg kg−1). P-values were determined using the two-sided, log[rank] (Mantel–Cox) test. *p < 0.05. C–G) Bacterial load (expressed as Log10 CFU) of E. coli B2 present in the heart (C), liver (D), spleen (E), lung (F), and kidney (G); this was evaluated at 48 h via a tenfold serial dilution technique. H) Representative photomicrographs of the H&E and Masson staining of the heart, liver, spleen, lung, and kidney. The arrow indicates the pathological lesions. The results are presented as the mean ± s.d. (n = 7). Significance was determined by Tukey’s multiple comparisons test following one-way ANOVA. ns, not significant. **p < 0.01 and ***p < 0.001.

    Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

    Article Title: A Milk Extracellular Vesicle-Based Nanoplatform Enhances Combination Therapy Against Multidrug-Resistant Bacterial Infections.

    doi: 10.1002/advs.202406496

    Figure Lengend Snippet: Figure 6. Improved of the therapeutic effect in a peritonitis–sepsis infection model in mice by using FMEV. A) Scheme of the experimental protocol for the mouse peritonitis–sepsis model. B) Survival rates of mice with peritonitis–sepsis (n = 7). Mice were infected with a lethal dose of E. coli B2 (4.0 × 107 CFU) in the presence of PBS, PB (8 mg kg−1), PLU (16 mg kg−1), PB + PLU (8 mg kg−1 + 16 mg kg−1), and FMEV (PB: 8 mg kg−1 + PLU: 16 mg kg−1). P-values were determined using the two-sided, log[rank] (Mantel–Cox) test. *p < 0.05. C–G) Bacterial load (expressed as Log10 CFU) of E. coli B2 present in the heart (C), liver (D), spleen (E), lung (F), and kidney (G); this was evaluated at 48 h via a tenfold serial dilution technique. H) Representative photomicrographs of the H&E and Masson staining of the heart, liver, spleen, lung, and kidney. The arrow indicates the pathological lesions. The results are presented as the mean ± s.d. (n = 7). Significance was determined by Tukey’s multiple comparisons test following one-way ANOVA. ns, not significant. **p < 0.01 and ***p < 0.001.

    Article Snippet: CAMHB broth (HB6231-1), BHI broth (HB8297-1), agar powder (HB8274-1), Salmonella chromogenic medium (HB7007-1), E. coli chromogenic medium (HB7003-7) were purchased from Haibo (Qingdao, China).

    Techniques: Infection, Serial Dilution, Staining